Found 5 matching trials
Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma
PHASE1This is a phase 1 study of an anti-CD40 monoclonal antibody (2141-V11) in c...
Location
Duke University Medical Center
D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients
PHASE1The purpose of this research study is to determine the safety and efficacy ...
Location
Duke University Medical Center
D2C7-IT + 2141-V11 Combination Post-resection in rGBM
PHASE1The purpose of this study is to assess the safety and efficacy of the combi...
Location
Duke University Medical Center
D2C7 for Adult Patients With Recurrent Malignant Glioma
PHASE1This is a Phase I study to determine the maximum tolerated dose (MTD) and/o...
Location
Preston Robert Tisch Brain Tumor Center at Duke
D2C7-IT With Atezolizumab for Recurrent Gliomas
PHASE1This is a phase 1 study of atezolizumab in combination with D2C7-IT, a dual...
Status
Active Not Recruiting
Location
Duke University Medical Center